Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Lichterfeld

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
The Lancet. HIV|October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Nature|January 4, 2023
Phenotypic signatures of immune selection in HIV-1 reservoir cellsWeiwei Sun, Ce Gao, Ciputra Adijaya Hartana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 21, 2020
Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in BotswanaSonya Davey, Gbolahan Ajibola, Kenneth Maswabi, et al.
AIDS (London, England)|April 15, 2020
HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of lifeGbolahan Ajibola, Sikhulile Moyo, Terrence Mohammed, et al.
AIDS (London, England)|June 17, 2004
HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversityMathias Lichterfeld, Xu G Yu, Daniel Cohen, et al.
Journal of Virology|May 12, 2007
Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I allelesHendrik Streeck, Mathias Lichterfeld, Galit Alter, et al.
Pathogens & Immunity|March 8, 2024
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2020
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of LifeKenneth Maswabi, Gbolahan Ajibola, Kara Bennett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral SuppressionGbolahan Ajibola, Pilar Garcia-Broncano, Kenneth Maswabi, et al.
The Journal of Infectious Diseases|August 31, 2006
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infectionHendrik Streeck, Heiko Jessen, Galit Alter, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
The Lancet. HIV|October 2, 2015
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trialThomas A Rasmussen, Martin Tolstrup, Christel R Brinkmann, et al.
Nature|January 4, 2023
Phenotypic signatures of immune selection in HIV-1 reservoir cellsWeiwei Sun, Ce Gao, Ciputra Adijaya Hartana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 21, 2020
Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in BotswanaSonya Davey, Gbolahan Ajibola, Kenneth Maswabi, et al.
AIDS (London, England)|April 15, 2020
HIV diagnostic algorithm requires confirmatory testing for initial indeterminate or positive screens in the first week of lifeGbolahan Ajibola, Sikhulile Moyo, Terrence Mohammed, et al.
AIDS (London, England)|June 17, 2004
HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversityMathias Lichterfeld, Xu G Yu, Daniel Cohen, et al.
Journal of Virology|May 12, 2007
Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I allelesHendrik Streeck, Mathias Lichterfeld, Galit Alter, et al.
Pathogens & Immunity|March 8, 2024
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2020
Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of LifeKenneth Maswabi, Gbolahan Ajibola, Kara Bennett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2021
Viral Reservoir in Early-Treated Human Immunodeficiency Virus-Infected Children and Markers for Sustained Viral SuppressionGbolahan Ajibola, Pilar Garcia-Broncano, Kenneth Maswabi, et al.
The Journal of Infectious Diseases|August 31, 2006
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infectionHendrik Streeck, Heiko Jessen, Galit Alter, et al.
Pageof 17